September 21, 2012
Astellas Pharma and High Energy Accelerator Research Organization (KEK; Tsukuba, Ibaraki Prefecture) announced on September 20 that they have concluded an agreement for collaborative research to discover new drugs for the treatment of neglected tropical diseases (NTDs). Using KEK’s synchrotron...read more